137 related articles for article (PubMed ID: 31872456)
1. Lack of association of TNFA, TNFRSF1B and TNFAIP3 gene polymorphisms with response to anti-tumor necrosis factor therapy in Japanese patients with psoriasis.
Ito M; Hirota T; Momose M; Ito T; Umezawa Y; Fukuchi O; Asahina A; Nakagawa H; Tamari M; Saeki H
J Dermatol; 2020 Apr; 47(4):e110-e111. PubMed ID: 31872456
[No Abstract] [Full Text] [Related]
2. Specific single nucleotide polymorphism genotypes and association of an IL-12B polymorphism with secondary failure of infliximab therapy in Japanese psoriasis patients.
Torii K; Morita A
J Dermatol Sci; 2020 Aug; 99(2):135-136. PubMed ID: 32576423
[No Abstract] [Full Text] [Related]
3. The role of Fcγ receptor polymorphisms in the response to anti–tumor necrosis factor therapy in psoriasis A pharmacogenetic study.
Julià M; Guilabert A; Lozano F; Suarez-Casasús B; Moreno N; Carrascosa JM; Ferrándiz C; Pedrosa E; Alsina-Gibert M; Mascaró JM
JAMA Dermatol; 2013 Sep; 149(9):1033-9. PubMed ID: 24048425
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic analysis of TNF, TNFRSF1A, and TNFRSF1B gene polymorphisms and prediction of response to anti-TNF therapy in psoriasis patients in the Greek population.
Vasilopoulos Y; Manolika M; Zafiriou E; Sarafidou T; Bagiatis V; Krüger-Krasagaki S; Tosca A; Patsatsi A; Sotiriadis D; Mamuris Z; Roussaki-Schulze A
Mol Diagn Ther; 2012 Feb; 16(1):29-34. PubMed ID: 22111980
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of
Matsuoka H; Kabata D; Taura A; Matsui T; Takahi K; Hirano F; Katayama M; Okamoto A; Suenaga Y; Suematsu E; Yoshizawa S; Ohmura K; Ito S; Takaoka H; Oguro E; Kuzuya K; Okita Y; Udagawa C; Yoshimura M; Teshigawara S; Harada Y; Isoda K; Yoshida Y; Ohshima S; Tohma S; Saeki Y
Scand J Rheumatol; 2020 May; 49(3):253-255. PubMed ID: 32406335
[No Abstract] [Full Text] [Related]
6. Genetic prediction of the effectiveness of biologics for psoriasis treatment.
Nishikawa R; Nagai H; Bito T; Ikeda T; Horikawa T; Adachi A; Matsubara T; Nishigori C
J Dermatol; 2016 Nov; 43(11):1273-1277. PubMed ID: 27129929
[TBL] [Abstract][Full Text] [Related]
7. Antinuclear antibody formation following administration of anti-tumor necrosis factor agents in Japanese patients with psoriasis.
Yanaba K; Umezawa Y; Honda H; Sato R; Chiba M; Kikuchi S; Asahina A; Nakagawa H
J Dermatol; 2016 Apr; 43(4):443-4. PubMed ID: 26662275
[No Abstract] [Full Text] [Related]
8. Polymorphisms associated with anti-TNF drugs response in patients with psoriasis and psoriatic arthritis.
Ovejero-Benito MC; Muñoz-Aceituno E; Reolid A; Fisas LH; Llamas-Velasco M; Prieto-Pérez R; Abad-Santos F; Daudén E
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):e175-e177. PubMed ID: 30653751
[No Abstract] [Full Text] [Related]
9. Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis.
van den Reek JMPA; Coenen MJH; van de L'Isle Arias M; Zweegers J; Rodijk-Olthuis D; Schalkwijk J; Vermeulen SH; Joosten I; van de Kerkhof PCM; Seyger MMB; Zeeuwen PLJM; de Jong EMGJ
Br J Dermatol; 2017 May; 176(5):1288-1296. PubMed ID: 27564082
[TBL] [Abstract][Full Text] [Related]
10. Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naïve and anti-tumor necrosis factor-α drug-resistant Japanese psoriasis cases.
Takahashi N; Noda S; Taniguchi T; Adachi M
Int J Dermatol; 2015 Oct; 54(10):1194-8. PubMed ID: 26016819
[TBL] [Abstract][Full Text] [Related]
11. Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis.
Gibellini L; De Biasi S; Bianchini E; Bartolomeo R; Fabiano A; Manfredini M; Ferrari F; Albertini G; Trenti T; Nasi M; Pinti M; Iannone A; Salvarani C; Cossarizza A; Pellacani G
PLoS One; 2016; 11(12):e0167757. PubMed ID: 27936119
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic biomarkers associated with antitumour necrosis factor drug response in moderate-to-severe psoriasis.
Ovejero-Benito MC; Cabaleiro T; Sanz-García A; Llamas-Velasco M; Saiz-Rodríguez M; Prieto-Pérez R; Talegón M; Román M; Ochoa D; Reolid A; Daudén E; Abad-Santos F
Br J Dermatol; 2018 Mar; 178(3):798-800. PubMed ID: 28369750
[No Abstract] [Full Text] [Related]
13. Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis.
Ovejero-Benito MC; Prieto-Pérez R; Llamas-Velasco M; Muñoz-Aceituno E; Reolid A; Saiz-Rodríguez M; Belmonte C; Román M; Ochoa D; Talegón M; Cabaleiro T; Daudén E; Abad-Santos F
Pharmacogenomics; 2018 Jan; 19(1):7-16. PubMed ID: 29192552
[TBL] [Abstract][Full Text] [Related]
14. Marked decrease in serum squamous cell carcinoma antigen level after antitumor necrosis factor alpha therapy in six cases of severe psoriasis.
Iriki H; Tanese K; Furuichi Y; Takeshita K; Saito M
Int J Dermatol; 2016 Jun; 55(6):e364-6. PubMed ID: 26696364
[No Abstract] [Full Text] [Related]
15. Genome-wide association analysis of psoriasis patients treated with anti-TNF drugs.
Ovejero-Benito MC; Muñoz-Aceituno E; Sabador D; Almoguera B; Prieto-Pérez R; Hakonarson H; Coto-Segura P; Carretero G; Reolid A; Llamas-Velasco M; Abad-Santos F; Daudén E
Exp Dermatol; 2020 Dec; 29(12):1225-1232. PubMed ID: 33058233
[TBL] [Abstract][Full Text] [Related]
16. The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients.
González-Lara L; Batalla A; Coto E; Gómez J; Eiris N; Santos-Juanes J; Queiro R; Coto-Segura P
Arch Dermatol Res; 2015 Jul; 307(5):405-12. PubMed ID: 25537528
[TBL] [Abstract][Full Text] [Related]
17. TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis.
Tejasvi T; Stuart PE; Chandran V; Voorhees JJ; Gladman DD; Rahman P; Elder JT; Nair RP
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):593-600. PubMed ID: 22113471
[TBL] [Abstract][Full Text] [Related]
18. Associations of TNFAIP3 variants with susceptibility to psoriasis vulgaris and psoriasis arthritis in a Japanese population.
Momose M; Hirota T; Kikuchi S; Inoue N; Umezawa Y; Nakagawa H; Saeki H; Tamari M; Asahina A
J Dermatol Sci; 2020 Dec; 100(3):220-222. PubMed ID: 32998836
[No Abstract] [Full Text] [Related]
19. Presence of antidrug antibodies correlates inversely with the plasma tumor necrosis factor (TNF)-α level and the efficacy of TNF-inhibitor therapy in psoriasis.
Kui R; Gál B; Gaál M; Kiss M; Kemény L; Gyulai R
J Dermatol; 2016 Sep; 43(9):1018-23. PubMed ID: 26892625
[TBL] [Abstract][Full Text] [Related]
20. TT genotype of rs10036748 in TNIP1 shows better response to methotrexate in a Chinese population: a prospective cohort study.
Yan KX; Zhang YJ; Han L; Huang Q; Zhang ZH; Fang X; Zheng ZZ; Yawalkar N; Chang YL; Zhang Q; Jin L; Qian DF; Li XY; Wu MS; Xu QH; Zhang XJ; Xu JH
Br J Dermatol; 2019 Oct; 181(4):778-785. PubMed ID: 31020648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
